Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response - Concepedia

Concepedia

Publication | Open Access

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

DOI Full Paper Access

150

Citations

30

References

2017

Year

Jan‐Patrick Stellmann, Markus Krumbholz, Tim Friede, Anna Gahlen, Nadja Borisow, Katrin Fischer, Kerstin Hellwig, Florence Pache, Klemens Ruprecht, Joachim Havla,

Journal of Neurology Neurosurgery & Psychiatry

Abstract

Age, antibody status and possibly previous attacks predict further attacks in patients treated for NMOSD. Azathioprine and rituximab are superior to interferon-β.

References

	Year	Citations

Page 1